Literature DB >> 1351857

Proliferating cell nuclear antigen expression in normal, preneoplastic, and neoplastic colonic epithelium of the rat.

K Yamada1, K Yoshitake, M Sato, D J Ahnen.   

Abstract

Expression of the proliferating cell nuclear antigen (PCNA) was examined in normal rat intestinal tissues and in carcinogen-treated nonneoplastic and neoplastic colonic mucosa. In the normal intestine, PCNA expression was confined to the expected region of the proliferative compartment. A strong correlation was observed between PCNA labeling index and both [3H]thymidine labeling index (R = 0.993, P = 0.007) and percent of cells in S phase as determined by flow cytometry (R = 0.982, P = 0.018) and between the location of the maximal staining for PCNA and [3H]thymidine (R = 0.997, P less than 0.05). In animals treated with dimethylhydrazine (DMH), crypt hyperplasia, an increased PCNA labeling index, and shifts in both the region of maximal and the upper extent of PCNA expression were observed during DMH exposure; significant crypt hyperplasia and expansion of the PCNA-positive compartment persisted after completion of DMH injections. The patterns of PCNA expression and bromodeoxyuridine incorporation were similar in DMH-induced tumors. It is concluded that PCNA immunohistochemistry can be used as a reliable marker of the proliferative compartment in both normal and neoplastic colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351857     DOI: 10.1016/0016-5085(92)91109-h

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer.

Authors:  N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis.

Authors:  E Ierardi; M Principi; R Francavilla; S Passaro; F Noviello; O Burattini; A Francavilla
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

3.  Proliferative activity of gastric epithelium in progressive stages of Helicobacter pylori infection.

Authors:  C Panella; E Ierardi; L Polimeno; T Balzano; M Ingrosso; A Amoruso; A Traversa; A Francavilla
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

4.  Differing proliferative responses in proximal and distal colons of growing rats fed food eaten by adenoma patients.

Authors:  V Liberman; A Nyska; H Kashtan; G Zajicek; F Lubin; P Rozen
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

5.  Ruminant gastrointestinal cell proliferation and clearance of Escherichia coli O157:H7.

Authors:  B A Magnuson; M Davis; S Hubele; P R Austin; I T Kudva; C J Williams; C W Hunt; C J Hovde
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Effect of dietary fat on colonic protein kinase C and induction of aberrant crypt foci.

Authors:  L M Lafave; P Kumarathasan; R P Bird
Journal:  Lipids       Date:  1994-10       Impact factor: 1.880

7.  Antiproliferative and apoptotic-inducing potential of ellagic acid against 1,2-dimethyl hydrazine-induced colon tumorigenesis in Wistar rats.

Authors:  Syed Umesalma; Ponnuraj Nagendraprabhu; Ganapasam Sudhandiran
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

8.  Flow cytometric analysis of DNA synthetic phase fraction of the normal appearing colonic mucosa in patients with colorectal neoplasms.

Authors:  S Nakamura; J Goto; Y Kitayama; J P Sheffield; I C Talbot
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  Proliferation kinetics of streptozotocin-induced renal tumours in mice.

Authors:  B Delahunt; P R Cartwright; A Thornton; P J Dady
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Inhibition of tumor progression and neoangiogenesis using cyclic RGD-peptides in a chemically induced colon carcinoma in rats.

Authors:  Jörg Haier; Ulrike Goldmann; Birgit Hotz; Norbert Runkel; Ulrich Keilholz
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.